BOOK
Oral Manifestations of Systemic Diseases, An Issue of Atlas of the Oral & Maxillofacial Surgery Clinics, E-Book
(2017)
Additional Information
Book Details
Abstract
This issue of the Atlas of the Oral and Maxillofacial Surgery Clinics, edited by Dr. Joel J. Napeñas, focuses on Oral Manifestations of Systemic Diseases. Articles will feature Evaluation of the Patient; Oral Manifestations of Gastrointestinal Disorders; Oral Manifestations of Immunodeficiencies and Transplantation Medicine; Oral Manifestations of Autoimmune and Connective Tissue Disorders; Oral Manifestations of Drug-induced Disorders; Oral Manifestations of Neurologic Disorders; Oral Complications of Nonsurgicial Cancer Therapies; Oral Complications of Hematologic Disorders; Oral Complications of Systemic Viral Infections; Oral Complications of Allergies and Immunologically Mediated Diseases; Oral Complications of Multi-Organ Disorders; Oral Complications of Endocrine Disorders; Oral Complications of Systemic Bacterial and Fungal Infections; Dental and Periodontal Manifestations of Systemic Disease; Oral Complications of Dermatologic Disorders, and more!
Table of Contents
Section Title | Page | Action | Price |
---|---|---|---|
Front Cover | Cover | ||
ATLAS OF THE ORAL AND MAXILLOFACIAL SURGERY CLINICS OF NORTH AMERICA | i | ||
Copyright | ii | ||
Contributors | iii | ||
CONSULTING EDITOR | iii | ||
EDITOR | iii | ||
AUTHORS | iii | ||
Contents | v | ||
Preface: Oral Manifestations of Systemic Diseases | v | ||
Introduction to Oral Manifestations of Systemic Diseases: Evaluation of the Patient | v | ||
Oral Manifestations of Gastrointestinal Disorders | v | ||
Oral Manifestations of Immunodeficiencies and Transplantation Medicine | v | ||
Oral Manifestations of Autoimmune and Connective TissueDisorders | vi | ||
Drug-Induced Oral Complications | vi | ||
Oral Complications of Nonsurgical Cancer Therapies | vii | ||
Oral Manifestations of Hematologic Disease | vii | ||
Oral Manifestations of Viral Infections | vii | ||
Oral Manifestations of Immunologically Mediated Diseases | viii | ||
Oral Complications of Multiorgan Disorders | viii | ||
Head and Neck Manifestations of Endocrine Disorders | ix | ||
Oral Complications of Systemic Bacterial and Fungal Infections | ix | ||
Oral Complications of Dermatologic Disorders | x | ||
ATLAS OF THE ORAL AND MAXILLOFACIAL\rSURGERY CLINICS OF NORTH AMERICA\r | xi | ||
FORTHCOMING ISSUES | xi | ||
March 2018 | xi | ||
September 2018 | xi | ||
PREVIOUS ISSUES | xi | ||
March 2017 | xi | ||
September 2016 | xi | ||
Preface:\rOral Manifestations of Systemic Diseases | xiii | ||
Introduction to Oral Manifestations of Systemic Diseases | 85 | ||
History of present condition and medical history | 85 | ||
Source and reliability | 85 | ||
Chief complaint | 85 | ||
History of present illness | 85 | ||
Past medical, family, and social history | 86 | ||
Occupational and environmental history | 86 | ||
Review of systems | 86 | ||
Examination | 86 | ||
Vital signs | 86 | ||
General evaluation | 86 | ||
Cranial nerve examination | 86 | ||
American Society of Anesthesiologists classification of physical status | 86 | ||
Head and neck examination | 87 | ||
Lymph nodes | 87 | ||
Muscles of mastication | 87 | ||
Temporomandibular joints | 88 | ||
Salivary glands | 88 | ||
Intraoral examination | 88 | ||
Imaging studies | 88 | ||
Intraoral radiographs | 88 | ||
Three-dimensional imaging | 88 | ||
Diagnostic tests and studies | 90 | ||
Urinalysis | 91 | ||
Blood testing | 91 | ||
Smear and culture | 91 | ||
Biopsy | 92 | ||
Biopsy techniques | 92 | ||
Mucosal biopsies | 92 | ||
Immunostaining and immunofluorescence | 92 | ||
Oral smears for cytology | 92 | ||
Oral brush biopsy | 92 | ||
Labial salivary gland | 92 | ||
References | 92 | ||
Oral Manifestations of Gastrointestinal Disorders | 93 | ||
Introduction | 93 | ||
Gastroesophageal reflux disease | 93 | ||
Medical management | 94 | ||
Oral manifestations and considerations | 94 | ||
Inflammatory bowel disease | 95 | ||
Ulcerative colitis | 95 | ||
Medical management | 95 | ||
Oral manifestations and considerations | 96 | ||
Crohn’s disease | 97 | ||
Oral manifestations and considerations | 97 | ||
Dental management | 97 | ||
Liver disease | 99 | ||
General overview | 100 | ||
Manifestations of liver disease | 100 | ||
Jaundice | 100 | ||
Portal hypertension | 100 | ||
Ascites | 101 | ||
Hepatic encephalopathy | 101 | ||
Splenomegaly | 101 | ||
Blood abnormalities | 101 | ||
Light stools or dark urine | 101 | ||
Peripheral edema | 101 | ||
Abdominal pain | 101 | ||
Oral manifestations and considerations | 101 | ||
Protection | 101 | ||
Other considerations | 101 | ||
Dental drugs | 102 | ||
Summary | 102 | ||
Acknowledgment | 102 | ||
References | 102 | ||
Oral Manifestations of Immunodeficiencies and Transplantation Medicine | 105 | ||
Introduction | 105 | ||
Early effects | 105 | ||
Mucositis | 105 | ||
Infection | 106 | ||
Viral | 106 | ||
Human herpes virus | 106 | ||
Fungal | 107 | ||
Candidiasis | 107 | ||
Deep fungal infections | 107 | ||
Bacterial | 108 | ||
Late effects | 108 | ||
Malignancy | 108 | ||
Graft versus host disease (lichenoid, xerostomia) | 108 | ||
Postinflammatory hypermelanosis | 109 | ||
Neutropenic ulcer | 109 | ||
Drug-related effects | 109 | ||
Drug-induced gingival hyperplasia | 109 | ||
Mammalian target of rapamycin inhibitor–associated stomatitis | 110 | ||
Other effects | 110 | ||
References | 111 | ||
Oral Manifestations of Autoimmune and Connective Tissue Disorders | 113 | ||
Introduction | 113 | ||
Autoimmune and autoinflammatory-related blistering and ulcerative diseases | 113 | ||
Pemphigus vulgaris | 113 | ||
Incidence, predilection, and genetics | 113 | ||
Clinical features | 113 | ||
Diagnosis and histopathology | 113 | ||
Treatment considerations | 114 | ||
Mucous membrane pemphigoid | 116 | ||
Incidence, predilection, and genetics | 116 | ||
Clinical features | 116 | ||
Diagnosis and histopathology | 116 | ||
Treatment considerations | 116 | ||
Oral lichen planus | 117 | ||
Incidence, predilection, and genetics | 117 | ||
Clinical features | 117 | ||
Diagnosis and histopathology | 117 | ||
Treatment considerations | 117 | ||
Behçet disease | 117 | ||
Incidence, predilection, and genetics | 118 | ||
Clinical features | 119 | ||
Diagnosis and histopathology | 119 | ||
Treatment considerations | 119 | ||
Connective tissue diseases | 119 | ||
Systemic lupus erythematosus | 119 | ||
Incidence, predilection, and genetics | 119 | ||
Clinical features | 120 | ||
Diagnosis and histopathology | 120 | ||
Differential diagnosis | 120 | ||
Treatment considerations | 120 | ||
Sjögren syndrome | 120 | ||
Incidence, predilection, and genetics | 121 | ||
Clinical features | 121 | ||
Diagnosis and histopathology | 122 | ||
Differential diagnosis | 123 | ||
Oral Complications of Nonsurgical Cancer Therapies | 133 | ||
Introduction | 133 | ||
Oral mucosal complications | 133 | ||
Mucositis | 133 | ||
Neutropenic ulcer | 134 | ||
Lichenoid, erythema, and ulcers (chronic graft-versus-host-disease) | 135 | ||
Pyogenic granuloma | 135 | ||
Targeted therapy–associated stomatitis | 135 | ||
Targeted therapy–associated lichenoid | 135 | ||
Chemotherapy-associated hyperpigmentation | 135 | ||
Targeted therapy–associated hyperpigmentation | 135 | ||
Salivary gland complications | 136 | ||
Salivary gland hypofunction | 136 | ||
Sialoadenitis | 138 | ||
Mucocele | 138 | ||
Musculoskeletal complications | 138 | ||
Osteoradionecrosis | 138 | ||
Medication-related osteonecrosis of the jaw | 138 | ||
Impaired mastication | 139 | ||
Swallowing dysfunction | 140 | ||
Speech disorder | 140 | ||
Restricted mouth opening in chronic graft-versus-host disease | 140 | ||
Sensory disturbances | 141 | ||
Dysgeusia | 141 | ||
Neuropathy: tooth neuropathy and orofacial neuropathy | 141 | ||
Teeth and gingivae | 142 | ||
Increased dental demineralization and caries (see dry mouth) | 142 | ||
Pulp necrosis and obliteration (chronic graft-versus-host disease) | 143 | ||
Gingival enlargement | 143 | ||
Desquamative gingivitis (chronic graft-versus-host disease) | 143 | ||
Acute periodontal infections | 144 | ||
Bleeding | 144 | ||
Infections: bacterial, viral, and fungal | 144 | ||
Malignancy | 145 | ||
Developmental disturbances of teeth and craniofacial growth occur in pediatric patients. | 146 | ||
Summary | 146 | ||
References | 146 | ||
Oral Manifestations of Hematologic Disease | 149 | ||
Introduction | 149 | ||
White blood cell disorders | 149 | ||
Lymphoma | 149 | ||
Non-Hodgkin lymphoma | 149 | ||
Epidemiology | 149 | ||
Clinical presentation | 149 | ||
Histopathology | 150 | ||
Differential diagnosis | 150 | ||
Treatment | 150 | ||
T-cell lymphoma | 151 | ||
Multiple myeloma | 151 | ||
Epidemiology | 151 | ||
Clinical presentation | 151 | ||
Histopathology | 151 | ||
Differential diagnosis | 151 | ||
Treatment | 151 | ||
Leukemia | 152 | ||
Epidemiology | 152 | ||
Clinical presentation | 152 | ||
General signs and symptoms | 152 | ||
Oral signs and symptoms | 152 | ||
Histopathology | 152 | ||
Differential diagnosis | 153 | ||
Treatment | 153 | ||
Dental considerations | 154 | ||
Neutropenia | 154 | ||
Epidemiology | 154 | ||
Clinical presentation | 154 | ||
Differential diagnosis | 154 | ||
Treatment | 154 | ||
Red blood cell disorders | 154 | ||
Iron deficiency anemia | 155 | ||
Causes of iron deficiency anemia | 155 | ||
Oral Manifestations of Viral Infections | 163 | ||
Introduction | 163 | ||
Herpes simplex type | 163 | ||
Description | 163 | ||
Epidemiology | 163 | ||
Primary oral herpes | 163 | ||
Clinical presentation and differential diagnosis | 163 | ||
Management | 163 | ||
Secondary oral herpes | 164 | ||
Clinical presentation | 164 | ||
Differential diagnosis | 164 | ||
Management | 164 | ||
Varicella-zoster virus | 165 | ||
Varicella zoster (chicken pox) | 165 | ||
Oral Manifestations of Immunologically Mediated Diseases | 171 | ||
Introduction | 171 | ||
Swellings | 171 | ||
Orofacial granulomatosis | 171 | ||
Description | 171 | ||
Prevalence | 171 | ||
Histopathology | 172 | ||
Diagnosis | 172 | ||
Treatment | 172 | ||
Ulcers | 173 | ||
Recurrent aphthous stomatitis | 173 | ||
Description | 173 | ||
Prevalence | 173 | ||
Clinical presentation | 173 | ||
Histopathology | 175 | ||
Diagnosis | 176 | ||
Treatment | 176 | ||
Behçet disease | 177 | ||
Description | 177 | ||
Prevalence | 177 | ||
Clinical presentation | 177 | ||
Histopathology | 177 | ||
Diagnosis | 177 | ||
Treatment | 178 | ||
Erythema multiforme | 178 | ||
Description | 178 | ||
Prevalence | 179 | ||
Clinical presentation | 179 | ||
Histopathology | 180 | ||
Diagnosis | 180 | ||
Treatment | 180 | ||
Red and white lesions | 181 | ||
Lichen planus | 181 | ||
Description | 181 | ||
Prevalence | 181 | ||
Clinical presentation | 181 | ||
Histopathology | 181 | ||
Diagnosis | 181 | ||
Treatment | 182 | ||
Oral lichenoid lesions | 182 | ||
Lichenoid contact reaction to dental materials, particularly amalgam | 182 | ||
Description | 182 | ||
Prevalence | 182 | ||
Clinical presentation | 182 | ||
Patch testing for allergy to amalgam or mercury | 182 | ||
Histopathology | 183 | ||
Diagnosis | 183 | ||
Differential diagnosis | 183 | ||
Treatment | 184 | ||
Contact stomatitis—cinnamon reaction | 184 | ||
Description | 184 | ||
Prevalence | 185 | ||
Clinical presentation | 185 | ||
Histopathology | 185 | ||
Diagnosis | 185 | ||
Treatment | 185 | ||
References | 185 | ||
Oral Complications of Multiorgan Disorders | 187 | ||
Amyloidosis | 187 | ||
Brief description | 187 | ||
Clinical features | 187 | ||
Incidence, predilection, genetics | 187 | ||
Histopathology | 188 | ||
Differential diagnoses | 188 | ||
Treatment considerations | 188 | ||
Sarcoidosis including Heerfordt syndrome | 188 | ||
Brief description | 188 | ||
Incidence, predilection, genetics | 188 | ||
Clinical features | 189 | ||
Histopathology | 189 | ||
Differential diagnosis | 189 | ||
Treatment considerations | 190 | ||
Granulomatosis with polyangiitis | 190 | ||
Brief description | 190 | ||
Incidence, predilection, genetics | 190 | ||
Clinical features | 190 | ||
Histopathology | 190 | ||
Differential diagnosis | 191 | ||
Treatment considerations | 191 | ||
IgG4-related disease | 191 | ||
Brief description | 191 | ||
Prevalence, predilection, genetics | 191 | ||
Presenting features | 191 | ||
Histopathology | 191 | ||
Differential diagnoses | 191 | ||
Treatment considerations | 192 | ||
Systemic sclerosis (systemic scleroderma) including CREST syndrome | 192 | ||
Brief description | 192 | ||
Incidence, predilection, genetics | 192 | ||
Clinical features | 192 | ||
Histopathology | 193 | ||
Differential diagnosis | 193 | ||
Treatment considerations | 193 | ||
References | 193 | ||
Further readings | 195 | ||
Amyloidosis | 195 | ||
IgG4-related disease | 195 | ||
Granulomatosis with polyangiitis | 195 | ||
Systemic sclerosis (systemic scleroderma) including CREST syndrome | 195 | ||
Head and Neck Manifestations of Endocrine Disorders | 197 | ||
Introduction | 197 | ||
Pituitary gland disorders | 197 | ||
Hypopituitarism | 197 | ||
Etiology and epidemiology | 197 | ||
Clinical manifestations | 197 | ||
Differential diagnosis | 197 | ||
Hyperpituitarism | 198 | ||
Etiology and epidemiology | 198 | ||
Clinical manifestations | 198 | ||
Differential diagnosis | 198 | ||
Treatment considerations | 198 | ||
Thyroid gland disorders | 199 | ||
Hypothyroidism | 199 | ||
Oral Complications of Systemic Bacterial and Fungal Infections | 209 | ||
Introduction | 209 | ||
Bacterial infections | 209 | ||
Tuberculosis | 209 | ||
Causative pathogen | 209 | ||
Clinical presentation | 209 | ||
Oral manifestations | 209 | ||
Oral Complications of Dermatologic Disorders | 221 | ||
Introduction | 221 | ||
Oral lichen planus | 221 | ||
Mucous membrane pemphigoid | 223 | ||
Pemphigus vulgaris | 224 | ||
Epidermolysis bullosa | 224 | ||
Psoriasis | 226 | ||
Further readings | 227 |